Acro Biomedical (ACBM) Shareholder's Equity Growth (1y) (2016 - 2025)
Acro Biomedical (ACBM) Shareholder's Equity Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.19% |
| Sep 30, 2025 | -51.53% |
| Jun 30, 2025 | -14.88% |
| Mar 31, 2025 | -13.69% |
| Dec 31, 2024 | -14.77% |
| Sep 30, 2024 | -19.15% |
| Jun 30, 2024 | -181.38% |
| Mar 31, 2024 | -165.05% |
| Dec 31, 2023 | -152.84% |
| Sep 30, 2023 | -148.69% |
| Jun 30, 2023 | -40.92% |
| Mar 31, 2023 | -36.12% |
| Dec 31, 2022 | -24.44% |
| Sep 30, 2022 | -13.38% |
| Jun 30, 2022 | -10.20% |
| Mar 31, 2022 | 2.28% |
| Dec 31, 2021 | -6.15% |
| Sep 30, 2021 | -23.78% |
| Jun 30, 2021 | -21.64% |
| Mar 31, 2021 | -28.52% |